Pyrimethamine Market to Witness Growth Owing to Antimalarial Demand

The Global Pyrimethamine Market is estimated to be valued at USD 1.28 Bn in 2025 and is expected to exhibit a CAGR of 5.6% over the forecast period 2025 to 2032.

Pyrimethamine, a potent antiparasitic agent primarily utilized in the treatment of malaria and toxoplasmosis, has become an indispensable component of global healthcare arsenals. Characterized by its ability to inhibit dihydrofolate reductase in protozoa, this therapeutic product offers high efficacy, rapid bioavailability, and relatively low cost compared with newer antimalarial formulations. Pharmaceutical companies and healthcare providers leverage its proven clinical track record.

Get more insights on, Pyrimethamine Market- https://www.patreon.com/po...

#CoherentMarketInsights #Pyrimethamine #PyrimethamineMarket #PyrimethamineMarketInsights #ProtozoaTreatment #EssentialMedicines

Pyrimethamine Market to Reach USD 1,650 Million, Globally, by 2030 at 5.0% CAGR: We Market Research

Pyrimethamine Market Outlook 2022-2030:
Pyrimethamine Market Growth size was estimated at USD 1,000 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% to reach approximately USD 1,650 million in 2030. Because pyrimethamine is resistant to many Plasmodium species, it is usually administered in conjunction with folinic acid and sulfa. The superoxide dismutase 1 gene, which codes for a protein associated with amyotrophic lateral sclerosis, has also been found to be inhibited by pyrimethamine.

What is Pyrimethamine?
Pyrimethamine is a folic acid antagonist that inhibits the dihydrofolate reductase enzyme, disrupting the reproduction of parasites such as Plasmodium (responsible for malaria) and Toxoplasma gondii.

Get free access to sample report @ https://wemarketresearch.c...